New York, NY, March 04, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global genotyping assay market was valued at approximately USD 11.9 billion in 2018 and is expected to generate around USD 46.9 billion by 2025, at a CAGR of around 21.8% between 2019 and 2025.

Genotyping is a technology used to identify genetic variation in the genomic sequence or allelic genes of an individual by comparing it against the reference sequence. Genotyping helps to explore genetic variants including structural changes in DNA and single nucleotide polymorphism (SNPs). The increasing prevalence of genetic disorders worldwide, decreasing cost of DNA sequencing, technological advancements in the field of genotyping, and growing use of genotyping for drug development are the major factors contributing toward the genotyping assay market globally. Additionally, the escalating demand for bioinformatics in drug discovery and data analysis, burgeoning popularity of personalized medicine, and increasing awareness about genotyping assay will further propel this market’s growth. Other factors anticipated to fuel the global genotyping assay market are increasing the need for rapid genotyping-based diagnostics tests and the rising number of increasing plant and animal genotyping research activities. However, the high cost of equipment used in genotyping assays may hamper the market growth in the future. Growing genotyping and sequencing research and development activities and massive demand for plant and animal genome analysis are to generate new growth opportunities for the genotyping assay market over the upcoming years.

Browse through 71 Tables & 38 Figures spread over 110 Pages and in-depth TOC on “Global Genotyping Assay Market: By Type, Technology, Services, Size, Industry Share, Segments, Analysis and Forecast 2018–2025”.

Request Free Sample Report of Global Genotyping Assay Market Report @ https://www.zionmarketresearch.com/sample/genotyping-assay-market

The global genotyping assay market segments are divided into products and services, technology, application, and end-user. Based on products and services, the market is segmented into genotyping services, reagents and kits, instruments and bioinformatics. The reagents and kits segment held the largest market share in 2018, owing to the large-scale use of reagents and kits for a wide range of genotyping applications, such as drug efficacy and safety assessment, animals and plants breed development and improvement, personalizing chronic disease treatment etc. Instruments are further segmented into sequencers and amplifiers and analyzers. Bioinformatics sub-segment includes software and services.

By technology, the market is segmented into microarrays, polymerase chain reaction (PCR), sequencing, capillary electrophoresis, matrix-assisted laser desorption/ionization-time of flight (MALDI-Tof) mass spectrometry, and others. Sequencing segment held the largest market share in 2018, due to technological advancements, decreasing the cost of sequencing, and increasing use of DNA sequencing technologies for various applications. Polymerase chain reaction (PCR) is further segmented into real-time PCR and digital PCR. Sequencing segment is further split into next-generation sequencing, pyrosequencing, and Sanger sequencing. Capillary electrophoresis technology segment is further split into amplified fragment length polymorphism (AFLP), restriction fragment length polymorphism (RFLP), and single-strand conformation polymorphism.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/genotyping-assay-market

Based on application, the market is split into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. Pharmacogenomics dominated the global market in 2018. The growing adoption of the genotyping assay is anticipated to drive the demand for diagnostics and personalized medicine in the future.

Pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others form the end-user segment of the market. Pharmaceutical and biopharmaceutical companies are expected to register the highest growth rate over the forecast time period.

Request for Discount: https://www.zionmarketresearch.com/requestdiscount/genotyping-assay-market

North America dominated the global genotyping assay market with the largest revenue share, i.e., about 40%, in 2018. Growing incidences of genetic disorders, technological advancements, the presence of major players, increasing need for personalized medicines, and decreasing costs of DNA sequencing are some factors driving the North American genotyping assay market. Other factors that contribute toward this regional market are increasing adoption of personalized medicines, cost and time reduction for clinical development, rising number of plant and animal breeding research activities for breed and yield improvement, the presence of developed healthcare infrastructure, increased healthcare expenditure, etc. North America is estimated to retain its leading position in the global genotyping assay market over the assessment period. The U.S. is a major country for the North American genotyping assay market followed by Canada. The U.S. held the largest regional share of about 80% in 2018, owing to increasing awareness about genetic disorders, increasing health awareness, and wide acceptance of personalized medicine and treatment.

The second largest region in the global genotyping assay market in 2018 was Europe. The increasing prevalence of genetic disorders, growing public and private investments for genotyping research, large number of R&D projects related to genotyping and sequencing, rising government funding for research and development, and need for personalized or patient-centric treatment are the factors that will contribute remarkably toward the genotyping assay market in this region. Germany, France, and UK are major countries in the European genotyping assay market. Germany held about 32% revenue share of the European genotyping assay market. UK is expected to exhibit the highest growth over the forecast period. Increasing genotyping assay applications in pharmacogenomics, drug discovery, plant and animal breeding, and agricultural biotechnology are other factors contributing toward the market in European countries, such as UK, Spain, Germany, Italy, France, etc.

Browse the full “Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/genotyping-assay-market

The Asia Pacific genotyping assay market is projected to experience the highest CAGR in the upcoming years, owing to the increasing prevalence of genetic disorders, large population base, increasing health awareness, rising healthcare expenditure, and growing investments for research activities by academic and research institutes and biopharmaceutical companies. Additionally, the focus of major players for exploring new growth opportunities in emerging countries like India and China will further augment the scope of the market in the region. Increasing adoption and awareness about personalized medicine will drive the demand for genotyping assay products and services in the Asia Pacific region. China and Japan are the major markets in the Asia Pacific region. Among the Asia Pacific countries, China held the largest revenue share of about 34% in 2018 followed by Japan, whereas India is expected to exhibit the highest CAGR over the forecast time period.

Latin America represents another important regional market and has witnessed moderate growth in the genotyping assay market in the last few years. It is projected to exhibit noticeable growth over the forecast time period. Brazil is a major contributor to the Latin American genotyping assay market, which held about 65% of the revenue share in 2018.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/genotyping-assay-market

The Middle Eastern and African genotyping assay market will exhibit sluggish growth in the upcoming years, due to the lack of developed healthcare infrastructure.

Some key players of the global genotyping assay market include Thermo Fisher Scientific, Inc., Illumina, Inc., Roche Diagnostics Limited, Danaher Corporation, Qiagen N.V., Fluidigm Corporation, Agilent Technologies, Inc., GE Healthcare, Integrated DNA Technologies, Inc., Genewiz, Inc., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., and Eurofins Scientific.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3874

This report segments the global genotyping assay market into:

Global Genotyping Assay Market: By Products and Services

  • Reagents and Kits
  • Genotyping Services
  • Instruments
    • Sequencers and Amplifiers
    • Analyzers
  • Bioinformatics
    • Software
    • Services

Global Genotyping Assay Market: By Technology

  • Polymerase Chain Reaction
    • Real-Time PCR
    • Digital PCR
  • Microarrays
  • Sequencing
    • Next-Generation Sequencing
    • Pyrosequencing
    • Sanger Sequencing
  • Capillary Electrophoresis
    • Amplified Fragment Length Polymorphism
    • Restriction Fragment Length Polymorphism
    • Single-Strand Conformation Polymorphism
  • Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-Tof) Mass Spectrometry
  • Others

Global Genotyping Assay Market: By Application

  • Pharmacogenomics
  • Diagnostics and Personalized Medicine
  • Animal Genetics
  • Agricultural Biotechnology 
  • Others

Global Genotyping Assay Market: By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostic & Research Laboratories
  • Academic Institutes
  • Others

Global Genotyping Assay Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://zmrindustryjournal.us  | http://zmrresearchnews.us | http://zmrmarketjournal.com  | https://zmrnewsjournal.us | http://zmrnewsmagazine.com | https://zmrnewsblog.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com